Search Results - "Pesavento, T. E."

Refine Results
  1. 1

    The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression by Von Visger, J. R., Gunay, Y., Andreoni, K. A., Bhatt, U. Y., Nori, U. S., Pesavento, T. E., Elkhammas, E. A., Winters, H. A., Nadasdy, T., Singh, N.

    Published in Clinical transplantation (01-08-2014)
    “…Recurrent glomerulonephritis is an important cause of kidney allograft failure. The effect of immunosuppression on recurrent IgA nephropathy (IgAN) is unclear…”
    Get full text
    Journal Article
  2. 2

    Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years by Cosio, Fernando G., Pesavento, Todd E., Osei, Kwame, Henry, Mitchell L., Ferguson, Ronald M.

    Published in Kidney international (01-02-2001)
    “…Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Post-transplant diabetes mellitus (PTDM) is…”
    Get full text
    Journal Article
  3. 3

    Patient survival after renal transplantation: I. The impact of dialysis pre-transplant by Cosio, Fernando G., Alamir, Amir, Yim, Susan, Pesavento, Todd E., Falkenhain, Michael E., Henry, Mitchell L., Elkhammas, Elmahdi A., Davies, Elizabeth A., Bumgardner, Ginny L., Ferguson, Ronald M.

    Published in Kidney international (01-03-1998)
    “…Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Patients on dialysis and recipients of renal transplants have higher…”
    Get full text
    Journal Article
  4. 4

    Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: Implications for graft survival by Cosio, Fernando G., Frankel, Wendy L., Pelletier, Ronald P., Pesavento, Todd E., Henry, Mitchell L., Ferguson, Ronald M.

    Published in American journal of kidney diseases (01-10-1999)
    “…De novo focal segmental glomerulosclerosis (FSGS) in renal allografts most often is diagnosed in association with chronic allograft nephropathy (CN). In this…”
    Get full text
    Journal Article
  5. 5

    Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients by Cosio, Fernando G., Pelletier, Ronald P., Pesavento, Todd E., Henry, Mitchell L., Ferguson, Ronald M., Mitchell, Lynn, Lemeshow, Stanley

    Published in Kidney international (01-03-2001)
    “…Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. Acute rejection (AR) is a strong predictor of renal allograft…”
    Get full text
    Journal Article
  6. 6

    Patient survival after renal transplantation: II. The impact of smoking by Cosio, Fernando G, Falkenhain, Michael E, Pesavento, Todd E, Yim, Susan, Alamir, Amir, Henry, Mitchell L, Ferguson, Ronald M

    Published in Clinical transplantation (01-08-1999)
    “…Renal transplant recipients have significantly higher mortality than individuals without kidney disease and the excess mortality is mainly due to…”
    Get full text
    Journal Article
  7. 7

    Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology by Cosio, Fernando G., Pelletier, Ronald P., Sedmak, Daniel D., Pesavento, Todd E., Henry, Mitchell L., Ferguson, Ronald M.

    Published in Kidney international (01-11-1999)
    “…Acute rejection (AR) is a strong predictor of renal graft survival, but the negative impact of AR on survival is variable, suggesting that other factors…”
    Get full text
    Journal Article
  8. 8

    Obese living kidney donors : Short-term results and possible implications by PESAVENTO, T. E, HENRY, M. L, FALKENHAIN, M. E, COSIO, F. G, BUMGARDNER, G. L, ELKHAMMAS, E. A, PELLETIER, R. P, FERGUSON, R. M

    Published in Transplantation (27-11-1999)
    “…Living kidney donation has increased recently as the shortage of cadaveric organs continues. This increase has occurred in part, due to expanded donor…”
    Get full text
    Journal Article
  9. 9

    Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study by Pesavento, T E, Jones, P A, Julian, B A, Curtis, J J

    “…Calcium channel blockers (CCB) are considered the agents of choice to treat hypertension in cyclosporine (CsA)-treated renal transplant patients. Verapamil,…”
    Get full text
    Journal Article
  10. 10

    Relationships between arterial hypertension and renal allograft survival in African-American patients by Cosio, F G, Falkenhain, M E, Pesavento, T E, Henry, M L, Elkhammas, E A, Davies, E A, Bumgardner, G L, Ferguson, R M

    Published in American journal of kidney diseases (01-03-1997)
    “…In previous studies, we showed that in African-American patients arterial hypertension during the first 6 months after transplantation is associated with a…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Clinical implications of the diagnosis of renal allograft infarction by percutaneous biopsy by COSIO, F. G, PESAVENTO, T. E, SEDMAK, D. D, FARHAN, N, PELLETIER, R. P, HENRY, M. L, ELKHAMMAS, E. A, BUMGARDNER, G. L, FERGUSON, R. M

    Published in Transplantation (27-08-1998)
    “…Herein we investigated the relationships between acute rejection (AR), infection, and renal allograft infarcts, particularly those infarcts that occur beyond…”
    Get full text
    Journal Article
  13. 13

    Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients by COSIO, F. G, ELKHAMMAS, E. A, HENRY, M. L, PESAVENTO, T. E, SEDMAK, D. D, PELLETIER, R. P, BUMGARDNER, G. L, FERGUSON, R. M

    Published in Transplantation (15-01-1998)
    “…The aim of this study was to assess whether kidney-pancreas transplantation (KPT) compromises the prognosis of kidney transplantation (KT). This study included…”
    Get full text
    Journal Article
  14. 14

    The risk of recurrent I g A nephropathy in a steroid‐free protocol and other modifying immunosuppression by Von Visger, J. R., Gunay, Y., Andreoni, K. A., Bhatt, U. Y., Nori, U. S., Pesavento, T. E., Elkhammas, E. A., Winters, H. A., Nadasdy, T., Singh, N.

    Published in Clinical transplantation (01-08-2014)
    “…Abstract Recurrent glomerulonephritis is an important cause of kidney allograft failure. The effect of immunosuppression on recurrent IgA nephropathy (Ig AN )…”
    Get full text
    Journal Article
  15. 15

    Patient survival after renal transplantation: IV. Impact of post-transplant diabetes by Cosio, Fernando G., Pesavento, Todd E., Kim, Sunny, Osei, Kwame, Henry, Mitchell, Ferguson, Ronald M.

    Published in Kidney international (01-10-2002)
    “…Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. The development of de novo diabetes mellitus is a serious complication of…”
    Get full text
    Journal Article
  16. 16

    Mycophenolate therapy of SLE membranous nephropathy by Spetie, Dan N., Tang, Yuxiao, Rovin, Brad H., Nadasdy, Tibor, Nadasdy, Gyongyi, Pesavento, Todd E., Hebert, Lee A.

    Published in Kidney international (01-12-2004)
    “…Mycophenolate therapy of SLE membranous nephropathy. The immunosuppressant mycophenolic acid (MMF) has been used successfully to manage proliferative forms of…”
    Get full text
    Journal Article
  17. 17

    Patient survival after renal transplantation III: The effects of statins by Cosio, Fernando G., Pesavento, Todd E., Pelletier, Ronald P., Henry, Mitchell, Ferguson, Ronald M., Kim, Sunny, Lemeshow, Stanley

    Published in American journal of kidney diseases (01-09-2002)
    “…Background: Kidney transplant recipients have high cardiovascular risk and an unfavorable cardiovascular risk profile, which frequently includes…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20